Maria Sharapova was suspended for two years from Tennis by the International Tennis Federation (ITF) on 8 June 2016 for using a prohibited drug.
• She will remain under suspension for two years, commencing on 26 January 2016.
• The Russian tennis sensation was provisionally banned in March 2016 after testing positive for meldonium at Australian Open in January 2016.
• Meldonium is a metabolic modulator that is included under section S4 (Hormone and Metabolic Modulators) of the 2016 WADA Prohibited List, and therefore is also prohibited under the Programme.
• Sharapova will serve a period of ineligibility of two years.
• Due to her prompt admission of her violation, that period of ineligibility should be back-dated under Article 10.10.3(b) of the Programme to commence from 26 January 2016 (the date of sample collection) and so should end at midnight on 25 January 2018.
• Her results at the 2016 Australian Open should be disqualified, with resulting forfeiture of the ranking points and prize money that she won at that event.
• The Tennis Anti-Doping Programme applies to all players competing at Grand Slam tournaments and events sanctioned by the ITF, ATP, and WTA.